11 purse brands making high-quality handbags worth the investment in 2025
Every woman needs a bag to make an entrance for her. Something that does the talking so she can use her words for the ...
Roche Gets FDA Approval for Breast Cancer Test
The Swiss pharmaceutical company said the FDA backed a label expansion for the Pathway HER2 (4B5) test to identify patients with HR-positive, HER2-ultralow metastatic breast cancer who could be ...
Roche Q4 Earnings Review: Solid All-Court Performance, But Quiet On GLP-1 Progress
Roche Holding AG delivered a strong set of 2024 earnings. Guidance for 2025 suggests this will be a transitional year ahead, ...
Deutsche Bank Keeps Their Sell Rating on Roche Holding AG (RHHVF)
Deutsche Bank analyst Emmanuel Papadakis maintained a Sell rating on Roche Holding AG (RHHVF – Research Report) today and set a price target ...
cweb13h
Roche Holding AG’s Strong Financial Performance in 2024
Earnings Per Share (EPS) of $1.20, surpassing the estimated $1.17, reflecting the company’s ability to exceed market expectations. Revenue reached approximately $34.1 billion, exceeding forecasts and ...
Roche Holding AG (RHHVF) Expands AI in Digital Pathology and Drug Development, Reports 9% Sales Growth in Q3 2024
We recently compiled a list of the Morgan Stanley’s 15 Best European AI Stocks. In this article, we are going to take a look ...
Roche Holding AG (RHHVF) Gets a Hold from Barclays
Barclays analyst Emily Field maintained a Hold rating on Roche Holding AG (RHHVF – Research Report) today and set a price target of CHF290.00.